The article highlights the role of implantable cardioverter defibrillators (ICDs) in the primary and secondary prevention of sudden cardiac death. It considers the results of multicenter studies comparing the efficacy of antiarrhythmic drugs and implantable devices in the primary and secondary prevention of sudden cardiac death, including that in patients with nonischemic cardiomyopathy and discusses quality of life in patients with ICDs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.17116/terarkh20178912103-109 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!